Hematologic Malignancies Testing Market Outlook, Industry Demand and Supply, Key Prospects, Pricing Strategies, Forecast and Top Manufacturers Analysis Report

 

 


The market growth is driven by the growing prevalence of multiple myeloma and Leukemia, along with increasing patient awareness regarding benefits of early diagnosis of diseases

According to the current analysis by Emergen Research, the Global Hematologic Malignancies Testing Market size is expected to reach USD 5.45 Billion in terms of revenue from USD 1.95 Billion in 2019, delivering a CAGR of 14.6% through 2027.

Hematologic malignancies testing can be used to identify and diagnose disorders, classifying those with the help of hereditary variance instead of symptoms. The procedure enables more precise diagnosis and efficient therapies, thereby strengthening patients’ prognosis.

To get leading market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market

A SWOT analysis is performed on the leading companies engaged in the Hematologic Malignancies Testing market to offer a better understanding of the strengths, opportunities, weaknesses, and threats of the leading companies. It also covers production and consumption rate, the volatility of prices and demands, market share, market size, global position, and market position of each player

Key players in the global hematologic malignancies testing market are ArcherDx, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Invitae Corporation, Abbott Laboratories, NeoGenomics Laboratories, Inc., Cancer Genetics Inc., Asuragen, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies Corporation, among others.

Key Highlights From Report

In March 2020, Sysmex Corporation, a leading diagnostic solutions company, received Japan marketing clearance for the world's largest genome research organization, BGI Group’s coronavirus kit distribution. This initiative strengthened the company’s position in Japan.

Emergen Research has segmented the Global Hematologic Malignancies Testing Market on the basis of product, technology, disease, end-use, and region:

·         Regional Outlook (Revenue, USD Billion; 2017-2027)

o    North America

1.      U.S.

2.      Canada

3.      Mexico

o    Europe

1.      Germany

2.      U.K.

3.      France

4.      BENELUX

5.      Rest of Europe

o    Asia Pacific

1.      China

2.      Japan

3.      South Korea

4.      India

5.      Rest of APAC

o    Latin America

1.      Brazil

2.      Rest of LATAM

o    Middle East & Africa

1.      Saudi Arabia

2.      U.A.E.

3.      Rest of MEA

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Comments

Popular posts from this blog

Fermented Food and Ingredients Market Demand, Size, Share, Scope & Forecast To 2027

Near-Infrared Imaging Market 2021 | Industry Trends, Technological Advancements, Competitive Landscape Analysis and Segmental Analysis

Healthcare Supply Chain Management Market Size, Future Trends, Segmentation, Gross Margin, Opportunity Assessment